Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
RaySearch Laboratories AB ( ($SE:RAY.B) ) has issued an update.
RaySearch Laboratories AB is set to showcase its latest innovations at RSNA 2025, focusing on advancements in ablation, diagnostic radiology, and radiation oncology. The company will introduce new technologies like an image-guided liver ablation module and the RayImaging radiology workstation, aiming to enhance clinical workflows and improve cancer care. These developments highlight RaySearch’s strategic shift towards comprehensive cancer care, integrating various treatment modalities into a cohesive ecosystem.
The most recent analyst rating on ($SE:RAY.B) stock is a Buy with a SEK255.00 price target. To see the full list of analyst forecasts on RaySearch Laboratories AB stock, see the SE:RAY.B Stock Forecast page.
More about RaySearch Laboratories AB
RaySearch Laboratories AB is a medical technology company specializing in innovative software solutions for enhanced cancer treatment. The company offers products such as the RayStation treatment planning system, RayCare oncology information system, and RayIntelligence oncology analytics system. RaySearch’s software is used in over 1,100 clinics across 47 countries, and the company is publicly listed on Nasdaq Stockholm.
Average Trading Volume: 142,321
Technical Sentiment Signal: Buy
Current Market Cap: SEK7.78B
For an in-depth examination of RAY.B stock, go to TipRanks’ Overview page.